Carette, H.
,
Zysman, M.
Morelot-Panzini, C.
Perrin, J.
Gomez, E.
Guillaumot, A.
Burgel, P. R.
Deslee, G.
Surpas, P.
Le Rouzic, O.
Perez, T.
Chaouat, A.
Roche, N.
Chabot, F.
Funding for this research was provided by:
Boehringer Ingelheim (1)
Pfizer Foundation (2)
Article History
Received: 6 December 2018
Accepted: 24 April 2019
First Online: 16 May 2019
Ethics approval and consent to participate
: The study protocol has been approved by the Ethics Committee of Versailles Saint Quentin University, authorization number 04–479, for the protection of human beings involved in biomedical research. The study has also been approved by CCTIRS (Comité Consultatif sur le Traitement de l’Information en matière de Recherche dans le domaine de la Santé), on January the 6th 2005 (04–479).All patients provided written consent.
: Not applicable.
: HC reports grants and personal fees from France Oxygène, personal fees from RIRL reseau d’insuffisance respiratoire de Lorraine, outside the submitted work.MZ reports grants and personal fees from BoehringerIngelheim, personal fees from Novartis, personal fees from Chiesi, personal fees from GSK outside the submitted work.CMP declares that she have no competing interests.JP declares that she have no competing interests.EG declares that she have no competing interests.AG declares that she have no competing interests.PRB reports personal fees from Aptalis, personal fees from Astra-Zeneca, grants and personal fees from Boehringer Ingelheim, personal fees from Chiesi, personal fees from GSK, personal fees from Novartis, personal fees from Pfizer, personal fees from Vertex, personal fees from Zambon, outside the submitted work;GD reports personal fees from Novartis, personal fees from Astra Zeneca, personal fees from BTG/PneumRx, personal fees from Chiesi, personal fees from Boehringer Ingelheim, outside the submitted work.PS reports grants and personal fees from Boehringer Ingelheim outside the submitted work.OLR reports grants and personal fees personal fees and non-financial support from AstraZeneca, Boehringer Ingelheim, Chiesi, Lilly and Novartis; non-financial support from GlaxoSmithKline, MundiPharma, Pfizer, Teva, Santelys Association, Vertex and Vitalaire, all outside the submitted work.TP reports personal fees from Boehringer Ingelheim, personal fees from Novartis, personal fees from GSK, personal fees from Chiesi, personal fees from Pierre Fabre, outside the submitted work.AC reports grants and personal fees from Boehringer Ingelheim, personal fees from Novartis, personal fees from Actelion, personal fees from GSK outside the submitted work.NR reports grants and personal fees from Boehringer Ingelheim, grants and personal fees from Novartis, personal fees from Teva, personal fees from GSK, personal fees from AstraZeneca, personal fees from Chiesi, personal fees from Mundipharma, personal fees from Cipla, grants and personal fees from Pfizer, personal fees from Sanofi, personal fees from Sandoz, personal fees from 3 M, personal fees from Zambon, outside the submitted work.FC reports grants and personal fees from AGEVIE, grants from ARAIRLOR, grants from Air Liquide, grants from Breas, grants from Covidien, grants from Philips, grants from Resmed, grants from Respironics, grants from Weinman and personal fees from Astra-Zeneca, personal fees from Boehringer Ingelheim, personal fees from GSK, personal fees from Novartis, outside the submitted work.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.